ArticleMultiple sclerosis journal - experimental, translational and clinical
Targeting alpha-4 integrin with natalizumab for intermediate uveitis associated with multiple sclerosis.
Aicee Dawn Calma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.